Discount rate |
3 % |
0-10 % |
No effect/All costs treated as recurrent |
Covers all likely discount rate applications [45] |
Cost per ACT treatment |
USD 1.25 |
Increased to USD 4 |
Cost per test administered rises from USD 4.39 to 4.83 |
Highest value found in WHO GPRM database for an adult dose |
Cost per RDT |
USD 0.47 |
Increased to USD 2 |
Cost per test administered rises from USD 4.39 to 6.32 |
Highest cost found in WHO GPRM database |
Cost per rented vehicle day |
USD 208 |
Decreased to USD 20 per day |
Cost per test administered falls from USD 4.39 to 3.65 |
Approximate daily capital cost of a vehicle based on WHO-CHOICE data |
Use of enumerators |
Included for training and field work |
Excluded for training and field work |
Cost per test administered falls from USD 4.39 to 3.60 |
Enumerators contribute substantially to research component and may be unnecessary for intervention only |
NGO supervision costs |
Included |
Excluded |
Cost per test administered falls from USD4.39 to 3.66 |
Ongoing NGO and international supervision may not be required if made a routine intervention |
Duration of intervention effect |
6 months |
Reduced to 3 months/Increased to one year |
Gross cost per case averted rises from USD73 to 145/Gross cost per case averted falls from USD 73 to USD 36 |
Duration of effect uncertain in effect analysis [12, 14, 15] |